Zymeworks Stock (NASDAQ: ZYME) stock price, news, charts, stock research, profile.
You can purchase shares of Zymeworks (NASDAQ:ZYME) through any online brokerage.
Other companies in Zymeworks’s space includes: Immunome (NASDAQ:IMNM), 89bio (NASDAQ:ETNB), Replimune Group (NASDAQ:REPL), Prothena Corp (NASDAQ:PRTA) and Tango Therapeutics (NASDAQ:TNGX).
Zymeworks has a consensus price target of $19.71.
The stock price for Zymeworks (NASDAQ: ZYME) is $12.57 last updated October 4, 2024 at 4:58 PM EDT.
There are no upcoming dividends for Zymeworks.
Zymeworks’s Q3 earnings are confirmed for Friday, November 1, 2024.
There is no upcoming split for Zymeworks.
Zymeworks is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.